Educational Tools for Neonatal Screening Consent
(MICI Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to implement an electronic consent education process for the retention and research use of residual dried bloodspots at four hospitals in Michigan and assess the impact of the new education, both on patients and hospital staff. The research team will recruit women who have just given birth to answer surveys about the Michigan BioTrust consent process. Surveys will be collected from participants in the hospital and again four weeks later. The research team will collect survey data from patient participants at each hospital prior to hospital staff implementation of the new education process and again after staff implementation.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Educational Website and Video, Electronic Consent Education Process, Michigan BioTrust Consent Process?
Research shows that using educational videos and interactive multimedia can improve understanding and confidence in informed consent processes, as seen in studies involving trauma surgery and biobanking. These methods help people better understand the information they need to make informed decisions.12345
Is the educational tool for neonatal screening consent safe for use in humans?
How does the treatment in the 'Educational Tools for Neonatal Screening Consent' trial differ from other treatments for neonatal screening consent?
Research Team
Erin Rothwell, MD
Principal Investigator
University of Utah
Eligibility Criteria
This trial is for adults over 18 who speak English, Spanish or Arabic and have just given birth at one of the four participating hospitals in Michigan. They should be patients in the Mother & Baby Unit and willing to provide feedback on a new consent process for using leftover blood samples from newborn screening.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-implementation Data Collection
Participants complete surveys about the BioTrust consent process before the new education process is implemented
Implementation and Intervention
Hospital staff provide access to a website with detailed information and a video about the Michigan BioTrust; participants complete surveys immediately after
Follow-up
Participants are monitored for decisional regret, decisional conflict, and knowledge scores at 4 weeks post-intervention
Post-implementation Data Collection
Hospital consenting and biobanking rates are obtained from state data 6 months after the end of data collection
Treatment Details
Interventions
- Educational Website and Video
Find a Clinic Near You
Who Is Running the Clinical Trial?
Erin Rothwell
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator